Standard Segment to Dominate Europe Home Sequential Compression Devices Market during 2020–2028   

According to a new market research study on “Europe Home Sequential Compression Devices Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Device Type, Type, and Application” is expected to reach US$ 405.94 million by 2028 from 262.91 US$ million in 2021. The market is estimated to grow at a CAGR of 6.4% from 2021 to 2028. The report provides trends prevailing in the Europe home sequential compression devices market along with the drivers and restraints pertaining to the market growth. Various rental services for medical devices being used in home care settings is the major factor driving the growth of the Europe home sequential compression devices market. However, issues presence of substitute therapies hinders the growth of Europe home sequential compression devices market.  

The Europe home sequential compression devices market is segmented on the bases of device type, type, application, and country. The Europe home sequential compression devices market, by type is segmented into alternate sequential compression device (ASCD), simultaneous sequential compression device (SSCD). The simultaneous sequential compression device (SSCD) segment held the largest share of the market in 2021. Europe home sequential compression devices market based on the type is segmented into standard and portable. In 2021, the standard segment is likely to hold the largest share of the market. The Europe home sequential compression devices market by application, is segmented into deep vein thrombosis (DVT), lymphedema management, chronic venous insufficiency (CVI) and others. The deep vein thrombosis (DVT), segment is likely to hold the largest share of the market in 2021. The Europe home sequential compression devices market, by country is segmented into France, Germany, Italy, UK, and Russia.  

The European economy is severely affected due to the exponential growth of COVID-19 cases in the region. Spain, Italy, Germany, France, and the UK are among the most affected European countries. As per the Worldometer, as of July 1st, 2021, Spain, the UK, Italy, Germany, and France recorded 3,808,960; 4,800,907; 4,259,909; 3,736,223; and 5,775,301, respectively. Resulting from these situations, the regional government has announced the local restrictions in countries and ordered them to follow the lockdown rules. However, the demand for home medical devices has been increasing as there is fear of COVID-19 infection outside. The COVID-19 pandemic has resulted in diversion of healthcare resources including workforce, critical supplies, emergency, and intensive care unit (ICU) facilities to the management of patients infected with SARS-CoV-2 virus. Elective interventions and surgical procedures in most European countries have been postponed and operating room resources have been diverted to manage the pandemic. Limitations on direct personal contact and physical (social) distancing have influenced access to care. Patients with venous and lymphatic disorders or vascular anomalies continue to need expert care within current public health constraints. In addition, there is growing evidence that COVID-19 may predispose patients to both arterial and venous thromboembolic (VTE) disease and extensive coagulopathies further complicating the prognosis of the affected patients. To facilitate triage in this situation European Venous Forum (EVF) and European College of Phlebology (ECoP) in collaboration with various international organizations has developed Venous and Lymphatic Triage and Acuity Scale (VELTAS) to rationalize and harmonize the management of these patients during this difficult period. Such a factors will support home sequential compression device adoption and will have positive impact on market.

AIROS Medical; Arjo Medical Devices; Breg Inc.; Cardinal Health Inc; DJO Global, Inc.; DSMAREF CO.LTD; and Mego Afek ltd. are among the leading companies in the Europe home sequential compression devices market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in 2021, The SVANTEK Team welcomed OHD, its new distributor situated in Birmingham, Alabama in the United States, in February 2021. AIROS Medical, Inc. has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market its updated AIROS 8 Sequential Compression Therapy device and garment system.   

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com